Vertex Pharmaceuticals (NASDAQ: VRTX) fell by 13% on Dec. 19, when the rare-disease drug developer reported some lackluster ...

We recently compiled a list of the Jim Cramer Talked About These 17 Stocks After The Fed’s Rate Cut. In this article, we are ...

Vertex stock was floundering even before Thursday when the company's non-opioid pain drug underperformed expectations in a midstage study.

UBS analyst Ashwani Verma raised the firm’s price target on Teva (TEVA) to $28 from $26 and keeps a Buy rating on the shares.

We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, we are going to take a look ...

Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with ...

Mallinckrodt, the nation’s biggest opioid pill maker, agreed to pay $1.7 billion in opioids damages in 2022 in its first ...

As many as 500,000 overdoses have been reversed in the United States, thanks to the medication, they added. Naloxone is now available over-the-counter, and is often handed out with prescriptions for ...

While mergers and acquisitions in the Vietnamese life insurance sector have been relatively quiet, M&As in the non-life insurance sector have been quite strong, with the participation of both foreign ...

Opioids are notoriously addictive, and NSAIDs can cause long-term damage to the stomach and kidneys. The idea of a painkiller that’s effective, non-addictive, and doesn’t wreck your body ...

Naloxone is now available over-the-counter, and is often handed out with prescriptions for opioid painkillers. "A soldier or a trauma doc will tell you the very first thing you need to do is to ...